Genmab — Maj 2021
-
EPS 1.96 2025 is to low. And more likely to be around 2.5-3.0... or I hope
-
If the margin is around 40 % it will reflect running cost of 18 bDKK - think about that number versus 2021
-
I know the numbers contains more uncertainty than safety
-
Utroligt hvad en dårlig jobrapport kan gøre ved røde aktiekurser.
-
-
Also good weekend to you E L .
-
BTK: Endelig comeback for US biotech, men foran vigtig modstand
https://www.proinvestor.com/investornyt/674898/btk-endelig-comeback-for-us-biotech-men-foran-vigtig-modstand -
En kommentar fra Artisan https://finance.yahoo.com/news/why-artisan-partners-reduced-genmab-170410133.html
-
JW har solgt lidt for at betale skat https://finance.yahoo.com/news/transactions-shares-linked-securities-genmab-175200092.html
-
Fred være med det.
-
Jeg solgte også nogle stykker omkring 2600-2700, så vi var flere om at handle den ned
-
Nogen sælger og nogen køber f.eks GS https://www.morningstar.com/stocks/xcse/gmab/ownership
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind